Cantor Fitzgerald Starts Ligand Pharma (LGND) at Buy; Fundamentally Undervalued; Building Momentum In 2012

Go back to Cantor Fitzgerald Starts Ligand Pharma (LGND) at Buy; Fundamentally Undervalued; Building Momentum In 2012
LIGAND PHARMA (NASDAQ: LGND) Delayed: 287.54 -8.75 (2.95%)
Previous Close $296.29    52 Week High $139.79 
Open $294.84    52 Week Low $82.07 
Day High $301.93    P/E 668.70 
Day Low $286.22    EPS $0.43 
Volume 272,287